GlassScriptPhysician profile
Tara D Martinez
NPI 1962693887
$17,672.37
in general payments reported to CMS, 2019-2025
24 companies · $7,311 in 2025
The $7,311 reported for 2025 was more than what 91% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.90 · 2020: $54.02 · 2021: $162 · 2022: $305 · 2023: $8,047 · 2024: $1,706 · 2025: $7,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,500 · Travel and Lodging: $5,069 · Food and Beverage: $2,486 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,500.00 |
| Travel and Lodging | $5,068.53 |
| Food and Beverage | $2,486.06 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,165.03 | 2023-2025 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| E.R. Squibb & Sons, L.L.C. | $495.29 | 2022-2024 | Zeposia |
| Coloplast Corp | $154.47 | 2019-2021 | |
| Tela Bio, INC. | $139.92 | 2024 | Ovitex 2s |
| Ethicon US, LLC | $136.54 | 2024-2025 | Echelon Circular, Echelon Flex |
| Pfizer INC. | $125.00 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.41 | 2019 | |
| Integra Lifesciences Corporation | $43.99 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Baudax Bio INC. | $33.92 | 2020 | |
| Lilly USA, LLC | $33.12 | 2024 | Omvoh |
| Harmony Biosciences LLC | $31.29 | 2022 | |
| Exact Sciences Corporation | $29.48 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $23.79 | 2022 | |
| Convatec INC. | $23.25 | 2024 | |
| Orphalan INC | $21.76 | 2024 | Cuvrior |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21.27 | 2024 | Ligasure |
| Janssen Biotech, INC. | $21.08 | 2025 | Tremfya |
| Amneal Pharmaceuticals LLC | $20.43 | 2024 | Crexont |
| Partner Therapeutics, INC. | $20.10 | 2020 | |
| Daiichi Sankyo INC. | $19.80 | 2024 | Injectafer |
| Abbvie INC. | $18.57 | 2021 | |
| Mallinckrodt Enterprises LLC | $17.46 | 2019 | |
| Merck Sharp & Dohme LLC | $17.37 | 2023 | Bridion |
| Lsi Solutions INC | $15.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.